If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStelrad Grp Regulatory News (SRAD)

Share Price Information for Stelrad Grp (SRAD)

Share Price is delayed by 15 minutes
Get Live Data
150.00    -5.00 (-3.23%)
Bid:
146.00
Ask:
154.00
Spread: 8.00 (5.479%)
Market Cap: £191.03m
SRAD Live PriceLast checked at - London Stock Exchange

Intraday Stelrad Grp Share Chart

Directorate change

20 Apr 2026 07:00

RNS Number : 9958A
Stelrad Group PLC
20 April 2026
 

20 April 2026

 

Stelrad Group PLC

 

Appointment of Independent Chair Designate

 

Directorate Changes

 

Stelrad Group plc ("Stelrad" or "the Group" or "the Company", LSE: SRAD) is pleased to announce the appointment of Martyn Coffey as Independent Non-Executive Director and Chair Designate with effect from 1 May 2026. 

 

Martyn will succeed Bob Ellis as Chair following the conclusion of the Company's Annual General Meeting on 20 May 2026. 

 

Martyn Coffey is an accomplished Non-Executive Director with extensive board experience across the manufacturing, HVAC, building materials and construction sectors. Martyn is currently a Non-Executive Director at Taylor Wimpey plc and a Non-Executive Director and Chair of the Remuneration Committee at Luceco plc. His distinguished executive career notably included 11 years as CEO of Marshalls plc, a FTSE 250 company, and as CEO of Baxi Group, manufacturer of heating and hot water solutions.

 

Bob Ellis, Chair of Stelrad said:

"I have greatly enjoyed my role as Chair since 2013 and supporting the Company's progress since its flotation in 2021. I am very pleased to welcome Martyn to the Board. He brings a strong external perspective, and I have every confidence in his leadership."

 

Commenting on his appointment, Martyn Coffey, Chair designate, said:

"I am delighted to be joining Stelrad and enthused by the opportunity ahead. Stelrad is a quality business with excellent prospects, and I am looking forward to working with Trevor, Leigh, the Board and wider team to deliver sustainable growth and drive value for our shareholders."

 

Trevor Harvey, Chief Executive Officer said:

"I would like to thank Bob for his leadership during his tenure as Chair. He has played a key role in Stelrad's continued development. I look forward to working with Martyn as our new Chair. He brings a valuable and complementary perspective from his executive and non-executive leadership roles, his experience in the UK listed company environment and his knowledge of the building products and HVAC industries."

 

In accordance with UKLR 6.4.8R, the Company confirms that Martyn Coffey has also held the following directorships in the past five years:

- Executive Director at Marshalls plc

- Non-Executive Director at Eurocell plc

 

The Board considers that Martyn Coffey will be independent on appointment as Chair for the purposes of the UK Corporate Governance Code.

 

There is no further information to be declared in accordance with UKLR 6.4.8R.

 

Directorate Changes

Bob Ellis will be resigning from his role as Board Chair with effect from the conclusion of the Company's 2026 AGM. Mr Ellis is expected to continue to serve on the Board. The Bregal Fund III LP (the "Company's Major Shareholder") has stated its intention to nominate Mr Ellis as one of its Non-Executive Director appointments pursuant to the relationship agreement with the Company, replacing Nicholas Armstrong who would retire from the Board at the conclusion of the 2026 AGM. 

 

Irrespective of Mr Ellis's nomination, or (re)election, as a director appointment of the Company's Major Shareholder, as a holder of 49.55% of the issued share capital of the Company, the Company's Major Shareholder will continue to be bound by the mandatory offer provisions under Rule 9 of the Takeover Code.

 

As previously announced, Martin Payne, Non-Executive Director and Chair of the Audit and Risk Committee, has notified the Board that he will not be standing for re-election and will retire from the Board at the conclusion of the 2026 AGM. A replacement Non-Executive Director and Chair of the Audit and Risk Committee will be appointed in due course.

 

 

- ENDS -

 

 

For further information:

 

Stelrad Group plc

Trevor Harvey, Chief Executive Officer

Leigh Wilcox, Chief Financial Officer

 

+44 (0) 191 261 3301

Sodali & Co

James White / Pete Lambie

stelrad@sodali.com

+44 (0)7855 432699 

 

 

Notes to Editors

Stelrad Group plc is Europe's leading specialist radiator manufacturer, selling an extensive range of hydronic, hybrid, dual fuel and electrical heat emitters to more than 500 customers in over 40 countries. These include standard, premium and low surface temperature (LST) steel panel radiators, towel warmers, decorative steel tubular, steel multicolumn and aluminium radiators.

 

The Group has five core brands: Stelrad, Henrad, Termo Teknik, DL Radiators and Hudevad. In the data reported by BRG Building Solutions for 2024, Stelrad extended its market leadership position, with 24.2% share by volume of the European steel panel radiator market, excluding Russia and Belarus. The Group is now market leader in six countries - the UK, France, Belgium, the Netherlands, Ireland and Denmark, with a top three position in a further 12 territories. 

 

Stelrad is headquartered in Newcastle upon Tyne in the UK and in 2025 employed 1,300 people, with manufacturing and distribution facilities in Çorlu (Turkey), Mexborough (UK), Moimacco (Italy) and Nuth (Netherlands), with a further commercial and distribution operation in Krakow (Poland).

 

The Group's origins date back to the 1930s and Stelrad enjoys long established commercial relationships with many of its customers, having served each of its top five current customers for over twenty years.

 

Further information can be found at: https://stelradplc.com/.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEDLFFQZLFBBD
Date   Source Headline
26th Jun 202611:00 amRNSDirector/PDMR Shareholding
18th Jun 20262:00 pmRNSAppointment of Audit and Risk Committee Chair
21st May 20262:00 pmRNSHolding(s) in Company
20th May 20264:00 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Trading Update
12th May 202612:00 pmRNSDirector/PDMR Shareholding
23rd Apr 20267:00 amRNSAnnual Report and Notice of Annual General Meeting
20th Apr 20267:00 amRNSDirectorate change
9th Apr 20264:19 pmRNSHolding(s) in Company
31st Mar 20262:00 pmRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSPreliminary announcement of final results
13th Mar 20267:00 amRNSPreliminary announcement of final results
5th Mar 20262:00 pmRNSDirector Declaration
2nd Mar 20264:43 pmRNSHolding(s) in Company
18th Feb 20262:00 pmRNSDirectorate change
30th Jan 20267:00 amRNSFull Year Trading Update
9th Dec 20257:00 amRNS£100m Facility Refinanced on Improved Terms
17th Nov 20257:00 amRNSTrading Update
11th Sep 20253:34 pmRNSCompany Secretary Change
10th Sep 20253:31 pmRNSHolding(s) in Company
9th Sep 20252:08 pmRNSHolding(s) in Company
8th Aug 20257:00 amRNSInterim Results
8th Jul 20254:55 pmRNSHolding(s) in Company
2nd Jul 202510:01 amRNSDirector/PDMR Shareholding
26th Jun 20255:28 pmRNSHolding(s) in Company
23rd May 202511:07 amRNSDirector/PDMR Shareholding
23rd May 20257:00 amRNSAppointment of Joint Corporate Broker
21st May 20255:26 pmRNSResult of AGM - Replacement
21st May 20254:52 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Trading Update
20th May 20254:37 pmRNSHolding(s) in Company
1st May 20252:35 pmRNSHolding(s) in Company
7th Apr 202511:39 amRNSHolding(s) in Company
1st Apr 202511:23 amRNSHolding(s) in Company
26th Mar 20257:00 amRNSAnnual Report and Notice of Annual General Meeting
17th Mar 20253:24 pmRNSDirector/PDMR Shareholding
17th Mar 20253:19 pmRNSDirector/PDMR Shareholding
7th Mar 20257:00 amRNSPreliminary announcement of final results
29th Jan 20251:22 pmRNSDirector/PDMR Shareholding
27th Jan 20257:00 amRNSTrading Update
22nd Nov 202410:31 amRNSDirector/PDMR Shareholding
14th Nov 20247:00 amRNSTrading Update and Capital Markets Event
1st Oct 20247:00 amRNSDirectorate Change
30th Sep 20241:56 pmRNSHolding(s) in Company
24th Sep 20247:00 amRNSNotice of Capital Markets Event
20th Sep 202410:59 amRNSDirector Declaration
12th Aug 20247:00 amRNSInterim Results
16th Jul 20242:58 pmRNSHolding(s) in Company
12th Jul 20244:46 pmRNSRetrospective Confirmation of Reduction of Capital
10th Jul 20247:00 amRNSAppointment of Joint Corporate Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.